Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro

Stimulation of epidermal growth factor receptor (EGFR) by ligand(s) leads to activation of signaling molecules including Stat1 and Stat3, two members of the signal transducers and activators of transcription (STAT) protein family. Activation of Stat1 and Stat3 was constitutive in transformed squamou...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of clinical investigation Vol. 102; no. 7; pp. 1385 - 1392
Main Authors Grandis, J R, Drenning, S D, Chakraborty, A, Zhou, M Y, Zeng, Q, Pitt, A S, Tweardy, D J
Format Journal Article
LanguageEnglish
Published United States 01.10.1998
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Stimulation of epidermal growth factor receptor (EGFR) by ligand(s) leads to activation of signaling molecules including Stat1 and Stat3, two members of the signal transducers and activators of transcription (STAT) protein family. Activation of Stat1 and Stat3 was constitutive in transformed squamous epithelial cells, which produce elevated levels of TGF-alpha, and was enhanced by the addition of exogenous TGF-alpha. Targeting of Stat3 using antisense oligonucleotides directed against the translation initiation site, resulted in significant growth inhibition. In addition, cells stably transfected with dominant negative mutant Stat3 constructs failed to proliferate in vitro. In contrast, targeting of Stat1 using either antisense or dominant-negative strategies had no effect on cell growth. Thus, TGF-alpha/EGFR-mediated autocrine growth of transformed epithelial cells is dependent on activation of Stat3 but not Stat1.
AbstractList Stimulation of epidermal growth factor receptor (EGFR) by ligand(s) leads to activation of signaling molecules including Stat1 and Stat3, two members of the signal transducers and activators of transcription (STAT) protein family. Activation of Stat1 and Stat3 was constitutive in transformed squamous epithelial cells, which produce elevated levels of TGF-alpha, and was enhanced by the addition of exogenous TGF-alpha. Targeting of Stat3 using antisense oligonucleotides directed against the translation initiation site, resulted in significant growth inhibition. In addition, cells stably transfected with dominant negative mutant Stat3 constructs failed to proliferate in vitro. In contrast, targeting of Stat1 using either antisense or dominant-negative strategies had no effect on cell growth. Thus, TGF-alpha/EGFR-mediated autocrine growth of transformed epithelial cells is dependent on activation of Stat3 but not Stat1.
Author Zhou, M Y
Grandis, J R
Chakraborty, A
Pitt, A S
Drenning, S D
Zeng, Q
Tweardy, D J
AuthorAffiliation Department of Otolaryngology, University of Pittsburgh School of Medicine and the University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA. jgrandis@vms.cis.pitt.edu
AuthorAffiliation_xml – name: Department of Otolaryngology, University of Pittsburgh School of Medicine and the University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA. jgrandis@vms.cis.pitt.edu
Author_xml – sequence: 1
  givenname: J R
  surname: Grandis
  fullname: Grandis, J R
  email: jgrandis@vms.cis.pitt.edu
  organization: Department of Otolaryngology, University of Pittsburgh School of Medicine and the University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA. jgrandis@vms.cis.pitt.edu
– sequence: 2
  givenname: S D
  surname: Drenning
  fullname: Drenning, S D
– sequence: 3
  givenname: A
  surname: Chakraborty
  fullname: Chakraborty, A
– sequence: 4
  givenname: M Y
  surname: Zhou
  fullname: Zhou, M Y
– sequence: 5
  givenname: Q
  surname: Zeng
  fullname: Zeng, Q
– sequence: 6
  givenname: A S
  surname: Pitt
  fullname: Pitt, A S
– sequence: 7
  givenname: D J
  surname: Tweardy
  fullname: Tweardy, D J
BackLink https://www.ncbi.nlm.nih.gov/pubmed/9769331$$D View this record in MEDLINE/PubMed
BookMark eNpVkclOwzAQhn0AQVnEEyD5BKeAJ7bj5MABVSxFlZBYzpbjTFqjJm4dp4i3J9CqgtNs32z6j8he61sk5AzYFYBKr5_GE65yuUdGjKWQFIrnh-So6z4YAyGkOCAHhcoKzmFEVi-46l3ABttIfU1fo4mcln2krY-_EVBjo1ub6HxLax8oLl2FoTELOgv-M85pPQBDPqDF5eAktMHKmYgVtbjYUZOWrl0M_oTs12bR4enWHpP3-7u38WMyfX6YjG-niRUMYiK5RBB1yUsAqMoyA5nlqRCpAiskRyszYYtS8SIHpWwm06xkqHKljFUVWH5MbjZzl305HGSHB4NZ6GVwjQlf2hun_1daN9czv9aS5UWeDf0X2_7gVz12UTeu-3nItOj7TmdFISUwNoCXG9AG33UB690OYPpHEL0VZCDP_56047Zq8G-h1IsM
CitedBy_id crossref_primary_10_1016_j_yexcr_2008_08_009
crossref_primary_10_1074_jbc_M106044200
crossref_primary_10_1593_neo_04571
crossref_primary_10_1093_annonc_mdu156
crossref_primary_10_1038_onc_2016_271
crossref_primary_10_1158_1940_6207_CAPR_14_0136
crossref_primary_10_1016_S0304_3835_00_00623_6
crossref_primary_10_1186_bcr38
crossref_primary_10_1371_journal_pone_0015945
crossref_primary_10_4161_onci_27215
crossref_primary_10_1007_s12272_022_01398_y
crossref_primary_10_1016_j_ijrobp_2003_09_095
crossref_primary_10_1016_j_canlet_2012_11_052
crossref_primary_10_1038_nrclinonc_2018_8
crossref_primary_10_1007_s12029_013_9555_x
crossref_primary_10_1053_j_seminoncol_2010_06_014
crossref_primary_10_1155_2011_982879
crossref_primary_10_1186_1476_4598_5_15
crossref_primary_10_1038_sj_onc_1203483
crossref_primary_10_1158_2159_8290_CD_13_0103
crossref_primary_10_1016_j_ijrobp_2009_07_1731
crossref_primary_10_1097_00005392_200208000_00095
crossref_primary_10_1073_pnas_98_4_1543
crossref_primary_10_1002_lary_21044
crossref_primary_10_1371_journal_pone_0061716
crossref_primary_10_1371_journal_pone_0031884
crossref_primary_10_1016_j_semcancer_2019_10_002
crossref_primary_10_1038_sj_onc_1206523
crossref_primary_10_1074_jbc_M301629200
crossref_primary_10_1016_j_oraloncology_2015_11_022
crossref_primary_10_1016_j_cellsig_2009_02_021
crossref_primary_10_2310_JIM_0b013e318292110a
crossref_primary_10_1007_s11060_015_1731_3
crossref_primary_10_1016_j_biomaterials_2009_11_003
crossref_primary_10_1158_1541_7786_MCR_08_0095
crossref_primary_10_2298_SARH0902098K
crossref_primary_10_1006_bbrc_1999_0684
crossref_primary_10_1016_j_pharmthera_2004_01_002
crossref_primary_10_1111_j_1745_7254_2005_00053_x
crossref_primary_10_1016_j_cellsig_2013_07_023
crossref_primary_10_1038_nrc2734
crossref_primary_10_1002_stem_170138
crossref_primary_10_1016_S0171_2985_00_80061_3
crossref_primary_10_1074_jbc_M609798200
crossref_primary_10_1158_1535_7163_1533_3_12
crossref_primary_10_3892_mmr_2015_3716
crossref_primary_10_1002_jcp_22767
crossref_primary_10_1038_sj_onc_1208719
crossref_primary_10_1007_BF03403538
crossref_primary_10_1006_cimm_2000_1661
crossref_primary_10_1016_j_leukres_2017_09_022
crossref_primary_10_1021_bi052490j
crossref_primary_10_1016_j_canlet_2015_07_009
crossref_primary_10_1038_sj_onc_1203829
crossref_primary_10_1016_j_gpb_2019_09_008
crossref_primary_10_3109_07853890_2014_882105
crossref_primary_10_1038_sj_onc_1203947
crossref_primary_10_1530_ERC_13_0054
crossref_primary_10_1016_j_prp_2023_154760
crossref_primary_10_3748_wjg_v9_i2_271
crossref_primary_10_1158_0008_5472_CAN_13_2329
crossref_primary_10_1517_14728222_8_5_409
crossref_primary_10_1016_j_molonc_2016_03_001
crossref_primary_10_1016_S0304_3835_03_00345_8
crossref_primary_10_1111_j_1346_8138_2010_00827_x
crossref_primary_10_1158_2159_8290_CD_11_0218
crossref_primary_10_1371_journal_pone_0059798
crossref_primary_10_1200_JCO_2008_17_8251
crossref_primary_10_1016_S1050_1738_01_00066_4
crossref_primary_10_1158_1055_9965_EPI_08_0089
crossref_primary_10_3892_or_2014_3114
crossref_primary_10_1016_j_bmcl_2007_10_031
crossref_primary_10_1182_blood_2010_04_280123
crossref_primary_10_1016_j_jmb_2007_12_038
crossref_primary_10_1038_sj_bjc_6602055
crossref_primary_10_1007_s10822_007_9147_6
crossref_primary_10_1016_j_clcc_2012_09_002
crossref_primary_10_1002_jcb_10145
crossref_primary_10_1007_s13167_019_00177_y
crossref_primary_10_1046_j_1523_1755_2002_00206_x
crossref_primary_10_1038_s41467_017_01885_7
crossref_primary_10_1038_nri1995
crossref_primary_10_1371_journal_pone_0024071
crossref_primary_10_1111_eva_13240
crossref_primary_10_1186_s12885_015_1679_x
crossref_primary_10_1002_jcb_21272
crossref_primary_10_2217_imt_12_135
crossref_primary_10_1158_1078_0432_CCR_07_4923
crossref_primary_10_1196_annals_1378_063
crossref_primary_10_4049_jimmunol_166_12_7486
crossref_primary_10_1002_smll_202107712
crossref_primary_10_1158_1078_0432_CCR_0714_3
crossref_primary_10_1038_s12276_020_00551_1
crossref_primary_10_1096_fj_02_0597com
crossref_primary_10_1158_1078_0432_CCR_10_0333
crossref_primary_10_1016_j_ejcb_2007_05_009
crossref_primary_10_1111_apm_12407
crossref_primary_10_1016_j_canlet_2008_05_035
crossref_primary_10_1021_jm050513m
crossref_primary_10_1158_1535_7163_21_3_1
crossref_primary_10_1096_fj_02_1084fje
crossref_primary_10_1016_j_jbior_2014_05_004
crossref_primary_10_2337_diabetes_52_9_2381
crossref_primary_10_3390_molecules21121626
crossref_primary_10_1158_1541_7786_170_2_3
crossref_primary_10_1593_neo_09266
crossref_primary_10_1007_s10555_005_5047_1
crossref_primary_10_3389_fcimb_2020_537650
crossref_primary_10_1002_biof_1041
crossref_primary_10_1097_TP_0b013e3181739d25
crossref_primary_10_3892_ijmm_2017_3122
crossref_primary_10_1016_j_bbcan_2012_10_002
crossref_primary_10_1084_jem_20080003
crossref_primary_10_1158_1535_7163_11_3_1
crossref_primary_10_4049_jimmunol_177_12_8381
crossref_primary_10_1158_1078_0432_CCR_09_2658
crossref_primary_10_3389_fimmu_2022_835997
crossref_primary_10_1074_jbc_M606754200
crossref_primary_10_1016_j_bbcan_2013_12_005
crossref_primary_10_1002__SICI_1097_0215_19991112_83_4_564__AID_IJC20_3_0_CO_2_Q
crossref_primary_10_1016_j_radonc_2013_08_036
crossref_primary_10_3390_cancers11101419
crossref_primary_10_1074_jbc_M314037200
crossref_primary_10_1111_j_0022_202X_2004_23497_x
crossref_primary_10_3390_ijms23147889
crossref_primary_10_1038_sj_onc_1209149
crossref_primary_10_1200_JCO_2005_04_8306
crossref_primary_10_1039_c0mb00268b
crossref_primary_10_1016_j_biopha_2019_109659
crossref_primary_10_1016_j_drup_2010_04_001
crossref_primary_10_1038_nrurol_2014_129
crossref_primary_10_1002__SICI_1098_1136_200005_30_3_253__AID_GLIA5_3_0_CO_2_O
crossref_primary_10_1128_JVI_77_11_6385_6393_2003
crossref_primary_10_3389_fonc_2016_00024
crossref_primary_10_1200_JCO_2008_20_6235
crossref_primary_10_1111_odi_12766
crossref_primary_10_1074_jbc_275_8_5748
crossref_primary_10_1158_1541_7786_MCR_07_2177
crossref_primary_10_1016_j_radonc_2004_12_018
crossref_primary_10_1016_j_ejphar_2020_173107
crossref_primary_10_1101_sqb_1999_64_425
crossref_primary_10_3390_ijms22020603
crossref_primary_10_1038_sj_bjc_6600618
crossref_primary_10_1038_cr_2008_18
crossref_primary_10_1038_onc_2014_72
crossref_primary_10_1016_S0002_9440_10_63940_5
crossref_primary_10_1007_s11010_005_3696_6
crossref_primary_10_1016_S0303_7207_01_00385_9
crossref_primary_10_4049_jimmunol_177_8_5032
crossref_primary_10_1016_j_ejca_2003_10_016
crossref_primary_10_1002_ijc_28112
crossref_primary_10_1002_jcb_20554
crossref_primary_10_1007_s00432_006_0139_z
crossref_primary_10_1016_j_semcancer_2020_03_016
crossref_primary_10_1038_sj_onc_1208635
crossref_primary_10_1016_j_oraloncology_2008_07_011
crossref_primary_10_1016_j_ydbio_2010_05_503
crossref_primary_10_1038_sj_bjc_6603234
crossref_primary_10_1016_j_cyto_2022_155916
crossref_primary_10_1158_1535_7163_MCT_05_0302
crossref_primary_10_2337_diabetes_51_12_3505
crossref_primary_10_3390_cancers16030492
crossref_primary_10_1002_jnr_10110
crossref_primary_10_1126_scisignal_2001083
crossref_primary_10_1517_14728214_2010_497754
crossref_primary_10_1371_journal_pone_0070498
crossref_primary_10_1128_MCB_19_11_7519
crossref_primary_10_1593_neo_06409
crossref_primary_10_1016_j_ejmech_2022_114858
crossref_primary_10_1097_00001622_200105000_00007
crossref_primary_10_1111_j_1365_2133_2005_06951_x
crossref_primary_10_1093_jnci_djn470
crossref_primary_10_1158_0008_5472_CAN_06_3075
crossref_primary_10_1002_ijc_21967
crossref_primary_10_3390_molecules20022728
crossref_primary_10_1038_sj_onc_1206109
crossref_primary_10_1038_onc_2017_164
crossref_primary_10_1074_jbc_M113_477786
crossref_primary_10_1007_s12035_016_0103_0
crossref_primary_10_1038_sj_onc_1207437
crossref_primary_10_1080_14756366_2020_1871336
crossref_primary_10_1002_jcb_28131
crossref_primary_10_1021_jf204362n
crossref_primary_10_1152_ajpcell_00263_2008
crossref_primary_10_1016_j_bj_2021_06_007
crossref_primary_10_1080_01635581_2010_509538
crossref_primary_10_1158_0008_5472_CAN_07_5115
crossref_primary_10_1158_1078_0432_CCR_11_2486
crossref_primary_10_1006_cyto_2002_1022
crossref_primary_10_1016_j_molcel_2013_07_009
crossref_primary_10_1517_13543784_2015_1020370
crossref_primary_10_1517_14712598_6_3_231
crossref_primary_10_3342_ceo_2015_8_3_275
crossref_primary_10_1016_j_tranon_2020_100919
crossref_primary_10_2119_2003_00001_Wu
crossref_primary_10_1080_03639045_2018_1539496
crossref_primary_10_1002_ijc_24567
crossref_primary_10_1038_sj_onc_1205499
crossref_primary_10_1038_onc_2012_260
crossref_primary_10_1016_j_oraloncology_2014_08_013
crossref_primary_10_1093_carcin_bgp211
crossref_primary_10_1038_onc_2016_124
crossref_primary_10_1091_mbc_12_4_931
crossref_primary_10_1007_s40496_015_0049_8
crossref_primary_10_1016_j_phymed_2024_155538
crossref_primary_10_1038_sj_onc_1203527
crossref_primary_10_1016_j_bcp_2006_02_009
crossref_primary_10_1046_j_1523_1755_2003_00133_x
crossref_primary_10_1007_PL00022009
crossref_primary_10_1038_sj_onc_1206479
crossref_primary_10_1080_1042819031000116670
crossref_primary_10_1517_14712590902735795
crossref_primary_10_1016_j_lungcan_2015_09_014
crossref_primary_10_1016_j_bbagen_2014_04_019
crossref_primary_10_1016_S1607_551X_09_70569_8
crossref_primary_10_1371_journal_pone_0158440
crossref_primary_10_1038_sj_onc_1205260
crossref_primary_10_1007_s11060_012_0981_6
crossref_primary_10_1158_1078_0432_1190_11_3
crossref_primary_10_3390_life11050423
crossref_primary_10_4155_fso_15_13
crossref_primary_10_1038_sj_onc_1205385
crossref_primary_10_1080_13813450802033958
crossref_primary_10_1080_14728222_2017_1306055
crossref_primary_10_1177_154411130401500505
crossref_primary_10_3390_cancers6010494
crossref_primary_10_1002_hed_10224
crossref_primary_10_1080_07357907_2022_2055050
crossref_primary_10_1186_s12917_015_0505_7
crossref_primary_10_1016_S0014_5793_02_02677_7
crossref_primary_10_1016_j_beha_2013_04_006
crossref_primary_10_1074_jbc_M107527200
crossref_primary_10_1158_1535_7163_MCT_09_0327
crossref_primary_10_3389_fphar_2017_00332
crossref_primary_10_3390_cancers13061251
crossref_primary_10_1016_j_cellsig_2013_01_007
crossref_primary_10_1097_00005537_200005000_00016
crossref_primary_10_1002_ijc_10398
crossref_primary_10_1158_1535_7163_MCT_08_0154
crossref_primary_10_1177_154405910808700104
crossref_primary_10_1182_blood_2009_03_213363
crossref_primary_10_1038_sj_onc_1203650
crossref_primary_10_1074_jbc_M000089200
crossref_primary_10_1371_journal_pone_0024923
crossref_primary_10_1038_sj_onc_1206122
crossref_primary_10_1099_0022_1317_83_7_1651
crossref_primary_10_1016_j_oraloncology_2021_105665
crossref_primary_10_1016_j_ajpath_2012_11_019
crossref_primary_10_1002_1521_1878_200102_23_2_161__AID_BIES1023_3_0_CO_2_0
crossref_primary_10_1002_lary_24700
crossref_primary_10_1158_1535_7163_261_3_3
crossref_primary_10_1158_1535_7163_MCT_05_0069
crossref_primary_10_18632_oncotarget_13527
crossref_primary_10_3892_or_2017_5670
crossref_primary_10_1053_j_seminoncol_2008_03_008
crossref_primary_10_1016_j_jocn_2013_03_006
crossref_primary_10_1111_j_1745_7254_2006_00277_x
crossref_primary_10_1172_JCI9940
crossref_primary_10_1007_s10555_005_1580_1
crossref_primary_10_1007_s10989_007_9099_7
crossref_primary_10_1158_1078_0432_CCR_05_0148
crossref_primary_10_1038_nrc1275
crossref_primary_10_1038_onc_2012_188
crossref_primary_10_1016_j_currproblcancer_2004_05_003
crossref_primary_10_1038_sj_onc_1205859
crossref_primary_10_1002_jcp_10364
crossref_primary_10_1007_BF02829454
crossref_primary_10_1074_jbc_M303499200
crossref_primary_10_3892_ijo_2012_1568
crossref_primary_10_1152_ajpgi_00253_2004
crossref_primary_10_1007_s12031_014_0341_4
crossref_primary_10_1016_j_ygyno_2005_05_032
crossref_primary_10_1038_s12276_020_00506_6
crossref_primary_10_1158_1078_0432_CCR_04_2102
crossref_primary_10_1210_en_2013_1933
crossref_primary_10_3390_cancers13153714
crossref_primary_10_1097_00004647_200109000_00007
crossref_primary_10_1038_sj_onc_1204086
crossref_primary_10_1038_sj_onc_1207803
crossref_primary_10_1158_0008_5472_CAN_03_4041
crossref_primary_10_1593_neo_06274
crossref_primary_10_1002_cncr_23615
crossref_primary_10_1038_onc_2009_279
crossref_primary_10_1186_s12986_017_0180_8
crossref_primary_10_1038_ng_3073
crossref_primary_10_1158_0008_5472_CAN_03_3197
crossref_primary_10_3389_fphar_2022_950109
crossref_primary_10_1182_blood_V97_11_3559
crossref_primary_10_1182_blood_2002_04_1204
crossref_primary_10_1158_1535_7163_MCT_11_0072
crossref_primary_10_1016_j_otc_2005_11_003
crossref_primary_10_1016_j_ejca_2021_03_009
crossref_primary_10_3390_cancers15235647
crossref_primary_10_3892_ol_2020_11555
crossref_primary_10_1002_cbin_12112
crossref_primary_10_1177_107327489900600617
crossref_primary_10_1371_journal_pone_0117781
crossref_primary_10_1158_1078_0432_CCR_07_1543
crossref_primary_10_1002_mc_20665
crossref_primary_10_3390_cancers6020926
crossref_primary_10_1172_JCI200421032
crossref_primary_10_1002_hed_21975
crossref_primary_10_1097_00054725_199902000_00007
crossref_primary_10_1074_jbc_M004112200
crossref_primary_10_1158_1078_0432_CCR_06_2582
crossref_primary_10_1016_S0016_5085_03_01064_3
crossref_primary_10_3892_ol_2011_423
crossref_primary_10_1007_s11805_006_0127_8
crossref_primary_10_1016_j_biocel_2020_105777
crossref_primary_10_1182_blood_2006_04_017434
crossref_primary_10_1038_sj_onc_1206966
crossref_primary_10_1093_jnci_djj020
crossref_primary_10_1111_jcmm_13945
crossref_primary_10_1016_S0167_8140_02_00131_7
crossref_primary_10_1002_1097_0320_20010801_44_4_338__AID_CYTO1125_3_0_CO_2_V
crossref_primary_10_1177_107327489900600501
crossref_primary_10_1046_j_1523_1755_2002_00283_x
crossref_primary_10_1593_tlo_10217
crossref_primary_10_1074_jbc_M500206200
crossref_primary_10_1097_00001622_199911000_00010
crossref_primary_10_1007_s11010_012_1437_1
crossref_primary_10_1158_1078_0432_CCR_04_1752
crossref_primary_10_1038_onc_2015_150
crossref_primary_10_1186_s12964_014_0039_9
crossref_primary_10_3727_096504018X15214994641786
crossref_primary_10_1124_mol_106_032284
crossref_primary_10_1111_j_1749_6632_2009_04911_x
crossref_primary_10_1007_s12672_023_00808_x
crossref_primary_10_1073_pnas_0534764100
crossref_primary_10_1002_pros_21397
crossref_primary_10_1038_oncsis_2013_18
crossref_primary_10_1093_jnci_djj038
crossref_primary_10_1158_1940_6207_CAPR_10_0249
crossref_primary_10_1038_sj_onc_1207703
crossref_primary_10_1111_j_1349_7006_2002_tb02176_x
crossref_primary_10_1016_j_celrep_2022_111390
crossref_primary_10_1046_j_1523_1747_2003_12239_x
crossref_primary_10_1507_endocrj_EJ21_0106
crossref_primary_10_1038_onc_2013_45
crossref_primary_10_4049_jimmunol_176_5_2933
crossref_primary_10_1016_S0022_5347_05_64741_6
crossref_primary_10_1073_pnas_97_8_4227
crossref_primary_10_1177_0271678X19830791
crossref_primary_10_1006_cyto_2001_0905
crossref_primary_10_1016_j_rvsc_2005_05_009
crossref_primary_10_1074_jbc_M407094200
crossref_primary_10_1038_sj_leu_2404323
crossref_primary_10_1210_endo_141_7_7551
crossref_primary_10_3892_etm_2011_187
crossref_primary_10_1038_s41388_018_0388_8
crossref_primary_10_1002_ijc_20482
crossref_primary_10_1016_j_intimp_2010_12_006
crossref_primary_10_1002_bip_20901
crossref_primary_10_1016_j_celrep_2014_08_047
crossref_primary_10_1016_j_currproblcancer_2007_04_001
crossref_primary_10_1016_S0531_5565_99_00078_9
crossref_primary_10_1053_gast_2002_37075
crossref_primary_10_1053_j_seminoncol_2004_09_010
crossref_primary_10_1111_j_1478_3231_2011_02631_x
crossref_primary_10_3892_ol_2018_9227
crossref_primary_10_1182_blood_2007_11_126680
crossref_primary_10_3389_fonc_2019_00048
crossref_primary_10_1016_S0092_8674_00_81959_5
crossref_primary_10_1016_j_bbamcr_2018_11_016
crossref_primary_10_1074_jbc_275_3_2147
crossref_primary_10_1016_j_molonc_2014_01_004
crossref_primary_10_1007_s11259_006_3335_z
crossref_primary_10_1158_1535_7163_1183_3_10
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1172/JCI3785
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EndPage 1392
ExternalDocumentID 10_1172_JCI3785
9769331
Genre Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: CA01760
– fundername: NCI NIH HHS
  grantid: CA72526
– fundername: NCI NIH HHS
  grantid: CA 72261
GroupedDBID ---
-~X
.55
.GJ
.XZ
08P
29K
2WC
354
3O-
53G
5GY
5RE
5RS
8F7
AAWTL
AAYOK
ABOCM
ABPMR
ACGFO
ACIHN
ACNCT
ACPRK
ADBBV
AEAQA
AENEX
AFCHL
AFFNX
AHMBA
AI.
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
ASPBG
AVWKF
AZFZN
BAWUL
CGR
CS3
CUY
CVF
D-I
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
EMB
F5P
FRP
GROUPED_DOAJ
GX1
HYE
H~9
IAO
IEA
IHR
INH
INR
IOF
IPO
J5H
KQ8
L7B
M1P
M5~
MVM
N4W
NPM
OBH
OCB
ODZKP
OFXIZ
OGEVE
OHH
OK1
OVD
OVIDX
P2P
P6G
RPM
TEORI
TR2
TVE
UHU
VH1
VVN
W2D
WH7
WOQ
WOW
X7M
XSB
YFH
YHG
YKV
YOC
ZGI
ZXP
ZY1
~H1
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c401t-535e14fb3b111dbb61568244271c453ec564c9b7398177c6526b0e7877ac7d1c3
IEDL.DBID RPM
ISSN 0021-9738
IngestDate Tue Sep 17 21:17:47 EDT 2024
Fri Oct 25 04:20:54 EDT 2024
Thu Sep 26 18:43:38 EDT 2024
Sat Sep 28 07:40:12 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c401t-535e14fb3b111dbb61568244271c453ec564c9b7398177c6526b0e7877ac7d1c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://www.jci.org/articles/view/3785/files/pdf
PMID 9769331
PQID 69955100
PQPubID 23479
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_508986
proquest_miscellaneous_69955100
crossref_primary_10_1172_JCI3785
pubmed_primary_9769331
PublicationCentury 1900
PublicationDate 1998-Oct-01
1998-10-1
19981001
PublicationDateYYYYMMDD 1998-10-01
PublicationDate_xml – month: 10
  year: 1998
  text: 1998-Oct-01
  day: 01
PublicationDecade 1990
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of clinical investigation
PublicationTitleAlternate J Clin Invest
PublicationYear 1998
References 2158859 - Cell. 1990 Apr 20;61(2):203-12
7621070 - Immunity. 1995 Jul;3(1):1-4
8939983 - J Biol Chem. 1996 Nov 22;271(47):30290-6
8977232 - Blood. 1996 Dec 15;88(12):4415-25
8339264 - Cancer Res. 1993 Aug 1;53(15):3579-84
1502203 - Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7836-9
1524803 - Eur Arch Otorhinolaryngol. 1992;249(5):243-7
8574972 - Nat Med. 1996 Feb;2(2):237-40
2334906 - Cancer Res. 1990 May 15;50(10):3113-8
1742894 - Clin Otolaryngol Allied Sci. 1991 Oct;16(5):466-9
8397445 - Science. 1993 Sep 24;261(5129):1739-44
8826952 - Cancer. 1996 Sep 15;78(6):1284-92
9041204 - Cancer Res. 1997 Mar 1;57(5):978-87
1501243 - J Membr Biol. 1992 Jun;128(2):81-9
7640654 - Cell Biol Int. 1995 May;19(5):373-88
8667988 - Laryngoscope. 1996 Jul;106(7):884-8
9625170 - J Natl Cancer Inst. 1998 Jun 3;90(11):824-32
7538664 - Proc Natl Acad Sci U S A. 1995 May 9;92(10):4215-8
8702638 - J Biol Chem. 1996 Aug 9;271(32):19483-8
8839834 - Blood. 1996 Oct 1;88(7):2442-9
1904421 - Jpn J Cancer Res. 1991 Apr;82(4):403-10
7716810 - Trends Genet. 1995 Feb;11(2):69-74
8657134 - Mol Cell Biol. 1996 Apr;16(4):1595-603
9242377 - Oncogene. 1997 Jul 24;15(4):409-16
8289831 - Mol Cell Biol. 1994 Feb;14(2):914-22
1459725 - Int J Cancer. 1992 Dec 2;52(6):862-6
7710952 - Br J Cancer. 1995 Apr;71(4):840-4
7541555 - Science. 1995 Jul 7;269(5220):81-3
8140422 - Science. 1994 Apr 1;264(5155):95-8
1733967 - J Biol Chem. 1992 Feb 5;267(4):2714-22
7515879 - J Biol Chem. 1994 Jun 10;269(23):16297-304
9002549 - FASEB J. 1996 Dec;10(14):1578-88
8541528 - Blood. 1995 Dec 15;86(12):4409-16
8887543 - EMBO J. 1996 Sep 2;15(17):4515-25
7490523 - J Endocrinol. 1995 Oct;147(1):11-23
8787685 - J Clin Invest. 1996 Sep 1;98(5):1218-30
9566874 - Mol Cell Biol. 1998 May;18(5):2545-52
2766286 - Cancer Res. 1989 Sep 15;49(18):5167-75
2752531 - Carcinogenesis. 1989 Aug;10(8):1553-6
2176154 - EMBO J. 1990 Dec;9(13):4477-84
8670868 - EMBO J. 1996 Jul 15;15(14):3651-8
9419415 - Cell Growth Differ. 1997 Dec;8(12):1267-76
8066447 - Science. 1994 Aug 19;265(5175):1093-5
8942998 - Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13704-8
References_xml
SSID ssj0014454
Score 2.2130554
Snippet Stimulation of epidermal growth factor receptor (EGFR) by ligand(s) leads to activation of signaling molecules including Stat1 and Stat3, two members of the...
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 1385
SubjectTerms Carcinoma, Hepatocellular
Carcinoma, Squamous Cell
Cell Division - drug effects
Cells, Cultured
DNA-Binding Proteins - metabolism
Epithelial Cells - cytology
Epithelial Cells - drug effects
Epithelial Cells - physiology
Head and Neck Neoplasms
Humans
Kinetics
Liver Neoplasms
Mouth Mucosa - cytology
Mouth Mucosa - drug effects
Mouth Mucosa - physiology
Receptor, Epidermal Growth Factor - drug effects
Receptor, Epidermal Growth Factor - physiology
Recombinant Proteins - pharmacology
STAT1 Transcription Factor
STAT3 Transcription Factor
Trans-Activators - metabolism
Transforming Growth Factor alpha - pharmacology
Transforming Growth Factor alpha - physiology
Tumor Cells, Cultured
Title Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro
URI https://www.ncbi.nlm.nih.gov/pubmed/9769331
https://search.proquest.com/docview/69955100
https://pubmed.ncbi.nlm.nih.gov/PMC508986
Volume 102
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYKUhEXVNqiLi3gQ69m4_UrPlarIkBaVKEicYtsxy4rgbNAlt_P2PEitty4JbITxePJzDfjeSD0s675xFrBialMIFwzQ4wxgojAQV_aVtqQ8p1nF_L0ip9fi-uSFPZYwiqjs_PjeHt3HOc3ObZycefGqzix8Z_ZFECFruV4A20Af64s9HJywLkolZcp0YrVQ6IsBT09Pp-eMVWLbfRRpw6AjK7rojcA8_84yVeK5-QT2imIEf8avmwXffDxM9qalTPxL-j-0qdo3uzmw13ACT4ybJc9jl2f7yhO2QuD7xUDSMU-tYUFiXyL_4EV3t_goesOBunnF3BBcE4oATCKk2N_Ness4qd5_9B9RVcnv_9OT0lppEAcmE89EUx4yoNlFiRbay2gGFmDXp8o6rhg3gnJnbaK6Zoq5aSYSFt5-JWVcaqlju2hzdhF_w1hFwQYgLQVwVW8DdoEQdsqUC08a4ErRzClkLRZDPUymmxnqElT6D9CRytSN8DLaR0m-m752EitAcBV1QjtDYR_eUXZsBGSazvyMp6KZK-PAO_kYtkDr-y_98HvaDtnIebwvR9os39Y-gOAIb09zHz3DAdH4Ao
link.rule.ids 230,315,730,783,787,888,27936,27937,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagCOgF8apYoK0PXN2N16_4iFZUu223QqiVeotsx6Yrtc7SZvn9jB1vxcKtt0R2omQ8nvlmPA-EvtQ1n1grODGVCYRrZogxRhAROOhL20obUr7z4lzOLvnJlbgqSWH3JawyOrs8ije3R3F5nWMrV7duvIkTG39fTAFU6FqOn6JnsF0rvrHRy9kB56LUXqZEK1YPqbIUNPX4ZDpnqha76LlOPQAZ3dZG_0HMfyMl_1I9x6_Rq4IZ8dfh296gJz6-RS8W5VT8Hfr1w6d43uzow13ACUAybNc9jl2f7yhO-QuD9xUDTMU-NYYFmXyDf4Id3l_joe8OBvnnV3BBcE4pATiKk2t_M2se8e9lf9e9R5fH3y6mM1JaKRAHBlRPBBOe8mCZBdnWWgs4Rtag2SeKOi6Yd0Jyp61iuqZKOSkm0lYeNrMyTrXUsT20E7voPyDsggATkLYiuIq3QZsgaFsFqoVnLfDlCKYUkjaroWJGky0NNWkK_UfocEPqBrg5_YeJvlvfN1JrgHBVNUJ7A-EfXlEWbITk1oo8jKcy2dsjwD25XPbALR8f--Ahejm7WJw1Z_Pz009oN-ck5mC-z2inv1v7fQAlvT3IPPgH-d7jYA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIqpeEK-KBdr6wDVNvH7FR7Sw6rZsVSEq9RbZjk1XapOlZPn9jJ2kYsuNWyI7UTIez3wzngfAx7LkU2sFz0xhQsY1M5kxRmQicNSXtpY2xHzn5YU8veJn1-J6B8oxFyYF7Tu7Omlu706a1U2KrVzfuXyME8svlzMEFbqU-boO-RN4ilu2kKOdPpwfcC6G-ss004qVfbosRW2dn80WTJViH57p2AeQ0W2N9A_MfBwt-Zf6mb-A5wNuJJ_673sJO755BXvL4WT8Nfz85mNMb3L2kTaQCCIZsZuONG2X7iiJOQy9B5YgVCU-NodFuXxLfqAt3t2QvvcOQRno13iRkZRWgpCURPf-OGvRkN-r7r59A1fzL99np9nQTiFzaER1mWDCUx4ssyjfamsRy8gStftUUccF805I7rRVTJdUKSfFVNrC44ZWxqmaOnYAu03b-LdAXBBoBtJaBFfwOmgTBK2LQLXwrEbenOCUgaTVuq-aUSVrQ02rgf4TOB5JXSFHx_8wjW83vyqpNcK4opjAQU_4h1cMCzYBubUiD-OxVPb2CHJQKpndc8y7_33wGPYuP8-rr4uL8_ewn9ISUzzfB9jt7jf-EHFJZ48SC_4BP__kcw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Requirement+of+Stat3+but+not+Stat1+activation+for+epidermal+growth+factor+receptor-+mediated+cell+growth+In+vitro&rft.jtitle=The+Journal+of+clinical+investigation&rft.au=Grandis%2C+J+R&rft.au=Drenning%2C+S+D&rft.au=Chakraborty%2C+A&rft.au=Zhou%2C+M+Y&rft.date=1998-10-01&rft.issn=0021-9738&rft.volume=102&rft.issue=7&rft.spage=1385&rft.epage=1392&rft_id=info:doi/10.1172%2FJCI3785&rft.externalDBID=n%2Fa&rft.externalDocID=10_1172_JCI3785
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9738&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9738&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9738&client=summon